Researchers at the University of Maryland School of Medicine (UMSOM) and University of Pennsylvania Perelman School of Medicine have identified a powerful combination of antivirals to treat COVID-19. The researchers showed that combining the experimental drug brequinar with either of the two drugs already approved by the U.S. Food and Drug Administration for emergency use, remdesivir or molnupiravir, inhibited growth of the SARS-CoV-2 virus in human lung cells and in mice.
Study shows new drug combination more effective against SARS-CoV-2
February 15, 2022
Related blog posts
New drug shows promise for fighting both COVID-19 and cancer
November 15, 2022